Funding for this research was provided by:
Center for Translational Molecular Medicine (041–201)
Received: 13 September 2020
Accepted: 17 September 2020
First Online: 18 December 2020
Ethics approval and consent to participate
: The Institutional Review Board approved the protocol of MARS (protocol no. 10–056C) and the use of an opt-out consent procedure, in which participants and their legal representatives were notified of the study in writing.
: Not applicable.
: The authors declare that they have no competing interests.